Effects of paracetamol combined with dextromethorphan in human experimental muscle and skin pain

Basic and Clinical Pharmacology and Toxicology

Volumn 101, Issue 3, 2007, Pages 172-176

  Olesen, Anne Estrup ^a,b   Staahl, Camilla ^a,b   Ali, Zahid ^c   Drewes, Asbjørn Mohr ^a,b   Arendt Nielsen, Lars ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXOFAN; DEXTROMETHORPHAN; PARACETAMOL; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; DRUG SENSITIVITY; ELECTROSTIMULATION; FEMALE; HUMAN; LOW DRUG DOSE; MALE; METHODOLOGY; MYALGIA; NORMAL HUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SINGLE BLIND PROCEDURE; SKIN PAIN; STATISTICAL ANALYSIS; STIMULUS RESPONSE; TEMPORAL SUMMATION; VOLUNTEER;

ACETAMINOPHEN; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MUSCLE, SKELETAL; PAIN; PHYSICAL STIMULATION; RECEPTORS, N-METHYL-D-ASPARTATE; SKIN; SODIUM CHLORIDE;

EID: 34547862038     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00095.x     Document Type: Article

References (35)

1. Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001 26 : 257 64.
2. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992 573 : 321 3.
3. Price DD, Mao J, Lu J, Caruso FS, Frenk H, Mayer DJ. Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain 1996 68 : 119 27.
4. Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 1992 135 : 67 70.
5. Bem JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Saf 1992 7 : 190 9.
6. Laska EM, Sunshine A, Zighelboim I et al. Effect of caffeine on acetaminophen analgesia. Clin Pharmacol Ther 1983 33 : 498 509.
7. Smith LA, Moore RA, McQuay HJ, Gavaghan D. Using evidence from different sources: an example using paracetamol 1000 mg plus codeine 60 mg. BMC Med Res Methodol 2001 10 : 1.
8. Arendt-Nielsen L. Induction and assessment of experimental pain from human skin, muscle and viscera. In : Jensen TS, Turner JA, Wiesenfeld-Hallin Z (eds). Progress in Pain Research and Management. IASP press, Seattle, WA, 1997 393 425.
9. Drewes AM, Gregersen H, Arendt-Nielsen L. Experimental pain in gastroenterology: a reappraisal of human studies. Scand J Gastroenterol 2003 38 : 1115 30.
10. Graven-Nielsen T, Segerdahl M, Svensson P, Arendt-Nielsen L. Methods for induction and assessment of pain in humans with clinical and pharmacological examples. In : Kruger L (ed). Methods in Pain Research. CRC press, Boca Raton, FL, 2001 263 304.
11. Staahl C, Drewes AM. Experimental human pain models: a review of standardised methods for preclinical testing of analgesics. Basic Clin Pharmacol Toxicol 2004 95 : 97 111.
12. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 1995 81 : 63 8.
13. Price DD, Mao J, Frenk H, Mayer DJ. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994 59 : 165 74.
14. Arendt-Nielsen L, Nielsen JC, Bjerring P. Double-blind, placebo controlled comparison of paracetamol and paracetamol plus codeine-a quantitative evaluation by laser induced pain. Eur J Clin Pharmacol 1991 40 : 241 7.
15. Prescott LF. Adverse Reactions and Interactions. Paracetamol: A Critical Bibliographic Review. Taylors and Francis, London, 2001 447 526.
16. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001 8 : 1153 7.
17. Gibson W, Arendt-Nielsen L, Graven-Nielsen T. Referred pain and hyperalgesia in human tendon and muscle belly tissue. Pain 2006 120 : 113 23.
18. Schulte H, Segerdahl M, Graven-Nielsen T, Grass S. Reduction of human experimental muscle pain by alfentanil and morphine. Eur J Pain 2006 10 : 733 41.
19. Staahl C, Reddy H, Andersen SD, Arendt-Nielsen L, Drewes AM. Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics. Basic Clin Pharmacol Toxicol 2006 98 : 201 11.
20. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain 2002 98 : 205 16.
21. Schulte H, Graven-Nielsen T, Sollevi A, Jansson Y, Arendt-Nielsen L, Segerdahl M. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers. Acta Anaesthesiol Scand 2003 47 : 1020 30.
22. Sun W, Wessinger WD. Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats. Life Sci 2004 75 : 1405 15.
23. Bickel A, Dorfs S, Schmelz M, Forster C, Uhl W, Handwerker HO. Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain 1998 76 : 317 25.
24. Kardelis AC, Meinberg TA, Sulte HR, Gound TG, Marx DB, Reinhardt RA. Effect of narcotic pain reliever on pulp tests in women. J Endod 2002 28 : 537 9.
25. Kilo S, Forster C, Geisslinger G, Brune K, Handwerker HO. Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain 1995 62 : 187 93.
26. Koppert W, Wehrfritz A, Korber N et al. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 2004 108 : 148 53.
27. Walker JS, Carmody JJ. Experimental pain in healthy human subjects: gender differences in nociception and in response to ibuprofen. Anesth Analg 1998 86 : 1257 62.
28. Petersen KL, Brennum J, Dahl JB. Experimental evaluation of the analgesic effect of ibuprofen on primary and secondary hyperalgesia. Pain 1997 70 : 167 74.
29. Burian M, Tegeder I, Seegel M, Geisslinger G. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther 2003 74 : 113 20.
30. Sycha T, Gustorff B, Lehr S, Tanew A, Eichler HG, Schmetterer L. A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects. Br J Clin Pharmacol 2003 56 : 165 72.
31. Hughes AM, Rhodes J, Fisher G, Sellers M, Growcott JW. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. Br J Clin Pharmacol 2002 53 : 604 12.
32. Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth 2000 47 : 585 96.
33. Kauppila T, Gronroos M, Pertovaara A. An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist. Pharmacol Biochem Behav 1995 52 : 641 4.
34. McConaghy PM, McSorley P, McCaughey W, Campbell WI. Dextromethorphan and pain after total abdominal hysterectomy. Br J Anaesth 1998 81 : 731 6.
35. Plesan A, Sollevi A, Segerdahl M. The N-methyl-D-aspartate-receptor antagonist dextromethorphan lacks analgesic effect in a human experimental ischemic pain model. Acta Anaesthesiol Scand 2000 44 : 924 8.